GRDN.NYSEGuardian Pharmacy Services, INC

Form 4: Guardian Pharmacy Services Director Sells Over 4 Million Shares Valued at $84 Million

Sentiment:

Insider Transaction Report 29 May 2025 4:15 PM

📋All filings for Guardian Pharmacy Services, INC

A director and 10% owner of Guardian Pharmacy Services, Inc., Thomas J. Salentine Jr., through Bindley Capital Partners I, LLC, sold over 4.1 million shares of Class A Common Stock for approximately $84 million.

Worse than expectedThe sale of over 4.1 million shares by a director and 10% owner, representing a significant portion of their holdings, is generally viewed as a negative signal by investors, suggesting a potential lack of confidence or a strategic divestment.

Summary

Thomas J. Salentine Jr., identified as both a Director and a 10% Owner of Guardian Pharmacy Services, Inc. (GRDN), reported significant sales of the company's Class A Common Stock.
On May 27, 2025, 3,508,905 shares were sold indirectly by Bindley Capital Partners I, LLC at a price of $20.16 per share.
On May 28, 2025, an additional 651,454 shares were sold indirectly by Bindley Capital Partners I, LLC at the same price of $20.16 per share.
The combined total of shares sold across these two transactions amounts to 4,160,359 shares.
The aggregate value of these sales is approximately $83,999,999.04.
Following these transactions, Bindley Capital Partners I, LLC's indirect beneficial ownership stands at 1,939,817 shares, while Thomas J. Salentine Jr. directly owns 35,714 shares.
These sales were executed in accordance with an Underwriting Agreement dated May 22, 2025.

Sentiment

Score: 3

Explanation: The sentiment is negative due to a significant insider sale by a director and 10% owner, which can be interpreted as a lack of confidence or a strategic divestment, potentially putting downward pressure on the stock price.

Negatives

A substantial sale of 4,160,359 shares by a director and 10% owner, Thomas J. Salentine Jr., through Bindley Capital Partners I, LLC, could be interpreted by the market as a negative signal, potentially indicating a lack of confidence or a strategic divestment by a major stakeholder.
The transaction represents a significant reduction in the indirect beneficial ownership of a key insider and large shareholder, which may raise concerns among other investors.

Risks

Potential for negative market reaction and downward pressure on Guardian Pharmacy Services' stock price due to the large insider share sale.
Reduced alignment of interests between a significant insider/10% owner and other shareholders as a result of the decreased equity stake.

Stakeholder Impact

Shareholders: May experience negative sentiment and potential downward pressure on the share price due to the large insider sale, which could be perceived as a lack of confidence from a key stakeholder.

Key Dates

Date	Description
05/22/2025	Date of the Underwriting Agreement governing the share sales.
05/27/2025	Date of the first reported transaction where 3,508,905 shares were sold.
05/28/2025	Date of the second reported transaction where 651,454 shares were sold.
05/29/2025	Date the Form 4 was signed by the Attorney-in-Fact.

Recommendation

sell

Keywords

Guardian Pharmacy Services, GRDN, SEC Form 4, Insider Trading, Share Sale, Director Sale, 10% Owner, Equity Transaction, Stock Sale, Bindley Capital Partners

Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.